Glaukos (GKOS) Stock: Buy, Sell, or Hold?
GKOS - Glaukos Corporation
$163.75
0.58 (0.36%)
▲
5d:
+6.04%
30d:
-8.79%
90d:
+10.12%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When GKOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GKOS is fairly valued with market pricing in 2.2% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: GKOS is fairly valued with market pricing in 2.2% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.68
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$10.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GKOS is currently trading at $163.75, which is considered slightly low relative to its 30-day fair value range of $159.69 to $179.14. The stock's valuation (Forward PE: 324.4) is in line with its historical norms (303.7). At these levels, the market is pricing in 2.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GKOS is in a strong uptrend. Immediate support is located at $151.01, while resistance sits at $168.73.
Market Sentiment: GKOS scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $198.69 (+21.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GKOS is in a strong uptrend. Immediate support is located at $151.01, while resistance sits at $168.73.
Market Sentiment: GKOS scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $198.69 (+21.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$159.69 -
$179.14
Company Quality Score
72/100
(BUY)
Options IV Signal
22th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
93.1%
Protect Your Profits
Holding GKOS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 22th percentile)
- BULLISH: Strong technical setup (85/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.3% below Wall St target ($198.69)
- NEUTRAL: Market pricing in 2.2% annual earnings growth - fairly valued
- CAUTION: Bottoming setup, but lagging the sector by 23% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$159.69 -
$179.14
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$13.54
(8.3%)
Support & Resistance Levels
Support Level
$151.01
Resistance Level
$168.73
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
324.45
Wall Street Target
$198.69
(+21.3%)
Revenue Growth (YoY)
49.5%
Earnings Growth (YoY)
1896.3%
Profit Margin
-30.7%
Valuation Premium vs History
+2.2% premium
PE vs Historical
324.5 vs 303.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.2%
(market-implied from PE analysis)
1-Year Target
$167.35
(+2%)
2-Year Target
$171.03
(+4%)
3-Year Target
$174.80
(+7%)
3-Yr Target (if PE normalizes)
(PE: 324→304)
PE COMPRESSION
$163.62
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 03, 2026 4:43 PM ET
Data refreshes hourly during market hours. Next update: 5:43 PM
Data refreshes hourly during market hours. Next update: 5:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GKOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$83 | 60 BUY |
Advanced GKOS Option Strategies
Professional options setups generated by AI based on today's GKOS price and gamma walls.
